This inventor holds 3 USPTO granted patents. Top assignee: Symphogen A/s. Active years: 2005-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Copenhagen, DK (2005)
- Charlottenlund, DK (2012)
- København, DK (2015)
Company Filing History:
Years Active: 2005-2015
Title: The Innovative Mind of John S. Haurum in the Field of Recombinant Antibodies
Introduction
John S. Haurum, an esteemed inventor based in København, Denmark, is recognized for his significant contributions to the biotechnology field. With a portfolio of three patents, he has made strides in developing methods for manufacturing recombinant polyclonal proteins and antibodies.
Latest Patents
One of Haurum's latest patents involves a novel method for manufacturing recombinant polyclonal protein compositions, especially focused on recombinant polyclonal antibody compositions. This method entails obtaining a collection of cells transfected with a library of variant nucleic acid sequences. Each cell in this collection is capable of expressing a distinct member of a polyclonal protein, specifically designed to bind a particular antigen.
Another noteworthy patent from Haurum is the method for producing anti-RhD recombinant polyclonal antibody compositions (anti-RhD rpAb). This innovative procedure includes a collection of cells transfected with anti-RhD antibody expression vectors, which encode members of the anti-RhD rpAb library. The cells are cultured under conditions that promote expression, ultimately leading to the production of antibodies which serve as superior replacements for plasma-derived therapeutic products.
Career Highlights
Haurum's dedication to scientific innovation is exemplified through his work at Symphogen A/S, where he continues to push the boundaries of antibody development. His research not only focuses on improving recombinant protein production methods but also on making therapeutic immunoglobulin products more accessible and effective for patients.
Collaborations
Throughout his career, Haurum has collaborated with notable professionals in the field, including Kirsten Drejer and Ulrik Gregers Winther Morch. These collaborations have fostered a dynamic exchange of ideas, contributing to advancements in their shared research endeavors.
Conclusion
John S. Haurum stands at the forefront of biotechnological innovation, particularly in the realm of recombinant antibodies. His inventive methodologies offer promising solutions for therapeutic applications, showcasing the vital role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile